Don’t forget fibratesA major meta-analysis of fibrate drugs has shown they modestly reduce the risk of major cardiovascular events, mainly through prevention of coronary artery disease and the need for revascularization. 2010 Canadian hypertension guidelines now available Consider panic in unexplained chest pain cases Warfarin patients often outside therapeutic range Smoking cancels benefit of alcohol on stroke risk Pneumococcal vaccine doesn’t reduce cardiac risk More patients reach LDL goals with rosuvastatin combo Aortic calcium indicates cardiac risk Stenting staves off amputation in critical limb ischemia Drug-eluting devices offer a new option for patients ineligible for vascular surgery Vitamin D deficiency not linked to myalgia in statin patients First Previous 77 78 79 80 81 Next Last
